Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Elad GoldbergMical Paul

Abstract

To assess the evidence for the current standard of practice of using empirical antifungal treatment in febrile neutropenic cancer patients. Systematic review and meta-analysis of randomised controlled trials comparing empirical or preemptive antifungal treatment with placebo, no intervention, or another antifungal. The primary outcomes were all-cause mortality and invasive fungal infections (IFI) (documented or probable). Relative risks (RR) with 95% confidence intervals (CI) were pooled. Six trials assessed the efficacy of empirical treatment compared to no treatment and one compared empirical to preemptive therapy. Empirical treatment did not decrease mortality significantly (RR 0.82, 95% CI 0.50-1.34), but significantly decreased IFIs (RR 0.25, 0.12-0.54). Twenty-three trials assessed the efficiency of different antifungals. All-cause mortality was lower with azoles compared to amphotericin B (AB) (RR 0.81, 0.65-1.01); IFI rates were not different while adverse events were less frequent with azoles (RR 0.40; 0.34-0.66). Liposomal AB was associated with lower mortality and IFIs than other AB formulations (RR 1.57, 1.10-2.23 and 1.48, 0.98-2.25, respectively). Caspofungin was associated with fewer adverse events, but otherwise...Continue Reading

References

Aug 19, 1976·The New England Journal of Medicine·J E Pennington
Jan 1, 1987·Antimicrobial Agents and Chemotherapy·V FainsteinK B McCredie
Nov 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J AnaissieG P Bodey
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H WhiteC B Miller
Dec 30, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M EllisB Vandercam
Jun 23, 2000·Journal of Pediatric Hematology/oncology·E S SandlerL Pietrelli
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Jan 25, 2002·The New England Journal of Medicine·Lawrence Corey, Michael Boeckh
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensJohan Van Eldere
Oct 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eyal RobenshtokMical Paul
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bart J RijndersSiem de Marie

❮ Previous
Next ❯

Citations

Jan 5, 2011·The Journal of Antimicrobial Chemotherapy·Samir AgrawalChristopher Kibbler
Mar 3, 2012·Haematologica·Johan A MaertensJ Peter Donnelly
Jun 8, 2011·Pediatric Reports·Mareva GiacchinoSimone Cesaro
Apr 28, 2011·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Noriyoshi IriyamaJin Takeuchi
Apr 24, 2010·Critical Reviews in Oncology/hematology·Jean KlasterskyMickael Aoun
Apr 28, 2009·Infectious Disease Clinics of North America·Leonard Leibovici, Matthew E Falagas
Apr 21, 2009·Clinics in Chest Medicine·George R ThompsonThomas F Patterson
May 2, 2012·Mycoses·Werner J Heinz, Florian Weissinger
Nov 24, 2012·Journal of Chemotherapy·Małgorzata MikulskaClaudio Viscoli
Mar 20, 2012·The Journal of Pediatrics·Rachel G GreenbergUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Aug 1, 2011·Therapeutic Advances in Hematology·Vijaya R BhattAlessandra Ferrajoli
Nov 22, 2018·Current Opinion in Pediatrics·Thomas Lehrnbecher
Jun 6, 2009·Current Opinion in Infectious Diseases·Ronen Ben-AmiDimitrios P Kontoyiannis
Feb 19, 2010·The Cochrane Database of Systematic Reviews·Christopher C BlythMichael H Bennett
Feb 19, 2016·Future Oncology·Rimas V LukasRavi Salgia
Apr 2, 2011·Current Opinion in Infectious Diseases·Aspasia Katragkou, Emmanuel Roilides
Jul 1, 2011·The Korean Journal of Internal Medicine·Dong-Gun LeeJung-Hyun Choi
Jun 15, 2011·Current Opinion in Infectious Diseases·Victor E Mulanovich, Dimitrios P Kontoyiannis
Mar 30, 2017·The Journal of Antimicrobial Chemotherapy·Toine Mercier, Johan Maertens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.